Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial.

Olsson AG, Schwartz GG, Szarek M, Sasiela WJ, Ezekowitz MD, Ganz P, Oliver MF, Waters D, Zeiher A.

Eur Heart J. 2005 May;26(9):890-6. Epub 2005 Mar 11.

PMID:
15764620
2.

Advances in drug treatment of dyslipidemia: focus on atorvastatin.

Davignon J.

Can J Cardiol. 1998 May;14 Suppl B:28B-38B. Review.

PMID:
9627539
4.

The next step in cardiovascular protection.

Cannon CP.

Atheroscler Suppl. 2003 Dec;4(5):3-9. Review.

PMID:
14980229
5.

Early initiation of treatment with statins in acute coronary syndromes.

Olsson AG, Schwartz GG.

Ann Med. 2002;34(1):37-41. Review.

PMID:
12014432
6.

What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?

Waters DD, Hsue PY.

Am J Cardiol. 2001 Oct 11;88(7B):7J-16J. Review.

PMID:
11595193
7.
8.

Early pharmacologic intervention and plaque stability in acute coronary syndromes.

Waters DD.

Am J Cardiol. 2001 Oct 18;88(8A):30K-36K. Review.

PMID:
11694217
9.

New evidence on pitavastatin: efficacy and safety in clinical studies.

Teramoto T, Shimano H, Yokote K, Urashima M.

Expert Opin Pharmacother. 2010 Apr;11(5):817-28. doi: 10.1517/14656561003641990. Review.

PMID:
20201733
10.

High-density lipoprotein-raising strategies: update 2010.

Spillmann F, Schultheiss HP, Tschöpe C, Van Linthout S.

Curr Pharm Des. 2010 May;16(13):1517-30. Review.

PMID:
20196737
11.

Is there a 'treatment gap' in acute coronary syndromes?

Krause BR, Newton RS.

Curr Opin Investig Drugs. 2003 Sep;4(9):1046-7. Review. No abstract available.

PMID:
14582446
12.

[Statins and unstable angina: MIRACL].

Puel J.

Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 2):145-8. Review. French.

PMID:
11240417
13.

Focusing on high-density lipoprotein for coronary heart disease risk reduction.

Davidson MH.

Cardiol Clin. 2011 Feb;29(1):105-22. doi: 10.1016/j.ccl.2010.11.005. Review.

PMID:
21257103
14.

Mechanistic insights and clinical relevance of the interaction between acute coronary syndromes and lipid metabolism.

Correia LC, Twickler MT, Sposito AC.

Semin Vasc Med. 2004 May;4(2):197-202. Review.

PMID:
15478041
15.

The role of lipid management in diabetes.

Ganda OP.

Cardiol Clin. 2005 May;23(2):153-64, vi. Review.

PMID:
15694744
16.

Exercise-mediated changes in high-density lipoprotein: impact on form and function.

Blazek A, Rutsky J, Osei K, Maiseyeu A, Rajagopalan S.

Am Heart J. 2013 Sep;166(3):392-400. doi: 10.1016/j.ahj.2013.05.021. Epub 2013 Jul 3. Review.

PMID:
24016485
17.

[Progress in hypocholesterolemic therapy in the prevention of recurrent infarction].

Manzato E, Zambon S, Crepaldi G.

Ann Ital Med Int. 1996 Oct;11 Suppl 2:127S-131S. Review. Italian.

PMID:
9004812
18.

Patient profile: secondary prevention.

Hobbs FD.

Int J Clin Pract Suppl. 2002 Jul;(130):13-4. Review. No abstract available.

PMID:
12296601
19.

[The reduction of cardiovascular events after a myocardial infarct in patients with normal cholesterol levels].

Hartley H.

Rev Clin Esp. 1996 Dec;196(4 Monografico):43-6. Review. Spanish. No abstract available.

PMID:
9139333
20.

Effect of lipid-lowering therapy on myocardial ischemia.

Tzivoni D, Klein J.

Cardiovasc Drugs Ther. 1998 Apr;12 Suppl 1:135-9. Review.

PMID:
9642487

Supplemental Content

Support Center